Stock Pick

Chorus’s 2025 regulatory report: RAB grows, revenue falls short

Written by

openjargon

in

A senior investor wearing glasses sits at his desk and works on his ASX shares portfolio on his laptop.

The Chorus Ltd (ASX: CNU) share price is in focus after the company published its 2025 fibre regulatory report, revealing a lift in its regulated asset base to $6.0 billion and a $76.3 million wash-up balance to be carried forward.

What did Chorus report?

  • Regulated Asset Base increased from $5.9 billion in 2024 to $6.0 billion for 2025
  • Core RAB reached $5.1 billion, up $0.2 billion from 2024
  • Financial Loss Asset reduced to $0.9 billion in 2025
  • 2025 revenues were $101 million below the maximum allowed
  • Operating costs for 2025 totalled $94 million (H2) and $97 million (H1) for core fibre
  • $129 million in capital expenditure in H2 2025, $178 million in H1 2025

What else do investors need to know?

The 2025 information disclosure highlights Chorus’ ongoing investments in expanding and maintaining its fibre network, with $343 million in new RAB assets commissioned during the year. The wash-up balance of $76.3 million, stemming from under-earning allowed revenue, will be carried forward to the next regulatory price-quality period (PQP3).

Chorus noted that both its financial numbers and regulatory calculations remain subject to review by the Commerce Commission. The company has also provided more detail for investors on its disclosures webpage.

What’s next for Chorus?

Looking ahead, Chorus is focused on supporting fibre connectivity across New Zealand and optimising its regulatory position for PQP3. The company continues to invest in upgrading its network assets and managing costs as it meets both customer needs and regulatory obligations.

Further updates are expected as the Commerce Commission reviews the submitted disclosures and as Chorus refines its strategy for future periods.

Chorus share price snapshot

Over the past 12 months, Chorus shares have declined 8%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 2% over the same period.

View Original Announcement

The post Chorus’s 2025 regulatory report: RAB grows, revenue falls short appeared first on The Motley Fool Australia.

Should you invest $1,000 in Chorus right now?

Before you buy Chorus shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Chorus wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

See the 5 Stocks

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More posts